Brendan B McCormick

Summary

Affiliation: University of Ottawa
Country: Canada

Publications

  1. doi request reprint Severe hypocalcemia following denosumab injection in a hemodialysis patient
    Brendan B McCormick
    Division of Nephrology, Department of Medicine, University of Ottawa, Ontario, Canada
    Am J Kidney Dis 60:626-8. 2012
  2. doi request reprint Metabolic effects of incremental doses of intraperitoneal amino acids on automated peritoneal dialysis
    Brendan B McCormick
    Division of Nephrology, Department of Medicine, The University of Ottawa, Ottawa, Ontario, Canada
    Perit Dial Int 30:201-7. 2010
  3. ncbi request reprint Noninfectious complications of peritoneal dialysis: implications for patient and technique survival
    Brendan B McCormick
    Division of Nephrology, Kidney Research Center, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    J Am Soc Nephrol 18:3023-5. 2007
  4. doi request reprint The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis
    Brendan B McCormick
    Division of Nephrology, Kidney Research Center, Ottawa Health Research Institute, Ottawa, Ontario, Canada
    Am J Kidney Dis 52:454-63. 2008
  5. doi request reprint Complications and catheter survival with prolonged embedding of peritoneal dialysis catheters
    Pierre Antoine Brown
    Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Nephrol Dial Transplant 23:2299-303. 2008
  6. pmc Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics
    Sunil V Badve
    Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Clin J Am Soc Nephrol 3:1711-7. 2008
  7. doi request reprint Pharmacologic treatment of hypertension in patients with chronic kidney disease
    Hari Talreja
    Department of Medicine, University of Ottawa, Ottawa, Canada
    Am J Cardiovasc Drugs 13:177-88. 2013
  8. doi request reprint BpTRUth: Do automated blood pressure monitors outperform mercury?
    Cedric Edwards
    Renal Hypertension Unit, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada Electronic address
    J Am Soc Hypertens 7:448-53. 2013
  9. doi request reprint Clinical hypotension with co-prescription of macrolide antibiotics and calcium-channel blockers in haemodialysis patients: a retrospective chart review
    Swapnil Hiremath
    The Renal Hypertension Unit, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada
    Drug Saf 36:989-93. 2013
  10. doi request reprint Spironolactone for difficult to control hypertension in chronic kidney disease: an analysis of safety and efficacy
    Jodi Heshka
    Department of Medicine, University of Ottawa, Ottawa, Ontario
    J Am Soc Hypertens 4:295-301. 2010

Collaborators

Detail Information

Publications16

  1. doi request reprint Severe hypocalcemia following denosumab injection in a hemodialysis patient
    Brendan B McCormick
    Division of Nephrology, Department of Medicine, University of Ottawa, Ontario, Canada
    Am J Kidney Dis 60:626-8. 2012
    ..We advise against the use of denosumab in those treated with hemodialysis due to the risk of severe hypocalcemia and lack of evidence supporting its efficacy in treating osteoporosis in this population...
  2. doi request reprint Metabolic effects of incremental doses of intraperitoneal amino acids on automated peritoneal dialysis
    Brendan B McCormick
    Division of Nephrology, Department of Medicine, The University of Ottawa, Ottawa, Ontario, Canada
    Perit Dial Int 30:201-7. 2010
    ..The use of amino acid (AA) dialysate to ameliorate protein-energy malnutrition has been limited by adverse metabolic effects...
  3. ncbi request reprint Noninfectious complications of peritoneal dialysis: implications for patient and technique survival
    Brendan B McCormick
    Division of Nephrology, Kidney Research Center, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    J Am Soc Nephrol 18:3023-5. 2007
    ..This clinical commentary focuses on these noninfectious complications of PD...
  4. doi request reprint The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis
    Brendan B McCormick
    Division of Nephrology, Kidney Research Center, Ottawa Health Research Institute, Ottawa, Ontario, Canada
    Am J Kidney Dis 52:454-63. 2008
    ..Pentoxifylline is a potential therapeutic agent for diabetic kidney disease because it has anti-inflammatory, antifibrotic, and hemorheological properties...
  5. doi request reprint Complications and catheter survival with prolonged embedding of peritoneal dialysis catheters
    Pierre Antoine Brown
    Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Nephrol Dial Transplant 23:2299-303. 2008
    ..We undertook this study to test the hypothesis that catheter survival on PD is a function of the time a catheter is left embedded prior to use...
  6. pmc Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics
    Sunil V Badve
    Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada
    Clin J Am Soc Nephrol 3:1711-7. 2008
    ..The objective of this study was to test the hypothesis that peritoneal phosphate clearance is better with continuous ambulatory PD (CAPD) as compared with continuous cyclic PD (CCPD) after adjusting for membrane transport status...
  7. doi request reprint Pharmacologic treatment of hypertension in patients with chronic kidney disease
    Hari Talreja
    Department of Medicine, University of Ottawa, Ottawa, Canada
    Am J Cardiovasc Drugs 13:177-88. 2013
    ..Most patients will require multi-drug therapy for achieving target blood pressure goals. This review discusses the pharmacologic options in management of hypertension in various forms of chronic kidney disease...
  8. doi request reprint BpTRUth: Do automated blood pressure monitors outperform mercury?
    Cedric Edwards
    Renal Hypertension Unit, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada Electronic address
    J Am Soc Hypertens 7:448-53. 2013
    ..The increased detection of white coat effect appears related to systematic downward bias by BpTRU. As a result, detection of masked effect is undermined by BpTRU. ..
  9. doi request reprint Clinical hypotension with co-prescription of macrolide antibiotics and calcium-channel blockers in haemodialysis patients: a retrospective chart review
    Swapnil Hiremath
    The Renal Hypertension Unit, Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada
    Drug Saf 36:989-93. 2013
    ..Since these drugs are frequently used in the haemodialysis population, we studied the effect of their co-prescription on actual blood pressure...
  10. doi request reprint Spironolactone for difficult to control hypertension in chronic kidney disease: an analysis of safety and efficacy
    Jodi Heshka
    Department of Medicine, University of Ottawa, Ottawa, Ontario
    J Am Soc Hypertens 4:295-301. 2010
    ..It is associated with a modest rise in serum potassium, which is more pronounced among those with glomerular filtration rate below 45 mL/minute...
  11. ncbi request reprint Review of clinical outcomes in nocturnal haemodialysis patients after renal transplantation
    Brendan B McCormick
    Division of Nephrology, Toronto General Hospital, University of Toronto, Ontario, Canada
    Nephrol Dial Transplant 19:714-9. 2004
    ..Current studies suggest that NHD lowers blood pressure through a decrease in peripheral resistance. The graft and blood pressure outcomes of NHD patients who undergo renal transplantation are unknown...
  12. ncbi request reprint The implications of the ADEMEX study for the peritoneal dialysis prescription: the role of small solute clearance versus salt and water removal
    Brendan B McCormick
    Toronto General Hospital, Ontario, Canada
    Curr Opin Nephrol Hypertens 12:581-5. 2003
    ....
  13. ncbi request reprint A case report of plasmapheresis and cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis: recovery of renal function after five months on dialysis
    Lily Oliveira
    Department of Medicine, Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada
    Ther Apher Dial 11:227-31. 2007
    ..This is the first report of late rescue from apparent ESRD due to FSGS with combined plasmapheresis and low dose oral cyclophosphamide...
  14. ncbi request reprint Extracorporeal management of valproic acid overdose: a large regional experience
    Sheldon M Singh
    Division of Nephrology, Department of Medicine, University of Toronto, ON, Canada
    J Nephrol 17:43-9. 2004
    ..Although extra-corporeal therapy has been proposed as beneficial in managing significant exposures, evidence to support its use is limited to isolated case reports. A systematic review has not been performed...
  15. doi request reprint Peritoneal dialysis catheter insertion strategies and maintenance of catheter function
    Nasim Shahbazi
    Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada
    Semin Nephrol 31:138-51. 2011
    ..Maintenance of catheter function is discussed with a focus on an organized and evidence-based approach to preventing and treating mechanical catheter problems...
  16. ncbi request reprint Improved blood pressure control with nocturnal hemodialysis: review of clinical observations and physiologic mechanisms
    Brendan B McCormick
    Toronto General Hospital, University Health Network, 200 Elizabeth Street, 12 EN 226, Toronto, Ontario, Canada M5G 2C4
    Curr Hypertens Rep 6:140-4. 2004
    ..Recent mechanistic studies exploring the reversal of the uremic hemodynamic state with NHD are also reviewed. The implication of these hemodynamic changes for the prospective renal transplant candidate are discussed...